Analysis of Hemoglobin Screening Effectiveness Using the Konsung Analyzer in Anemic Patients
Vanessa Chen
Jiangsu Konsung Biomedical Science and Technology Co., Ltd. Nanjing 210012, Jiangsu, China
Abstract: Anemia, a widespread disease globally, severely impacts the health and quality of life of hundreds of millions of people. Early screening is crucial for improving patient prognosis and reducing the disease burden. With medical resources being reduced to a grassroots level, there is an urgent need to develop accurate and convenient screening tools. This article focuses on the Konsung Hemoglobin Analyzer (H7 series) and discusses the practical application of its spectrophotometric detection principle in anemia screening. A systematic analysis of the device's operational parameters, data from multicenter clinical validation, and comparisons with traditional laboratory testing methods showed that the device demonstrates high accuracy (error range ± 2%) and high efficiency (3 seconds/sample) in quantitative hemoglobin determination. Its portable design and ease of use significantly simplify its application by primary healthcare personnel. It is particularly suitable for large-scale screening in primary healthcare facilities.
Keywords: hemoglobin analyzer; anemia screening; spectrophotometry; Konsung H7; diagnostic accuracy
1. Introduction
Anemia is a clinical syndrome characterized by a hemoglobin (Hb) level below normal, with a global prevalence of approximately 24.8%, of which 50% is attributed to iron deficiency anemia. Prolonged anemia not only leads to weakened immunity and impaired cognitive functions but can also cause cardiovascular and cerebrovascular diseases, posing a significant threat to certain population groups, such as pregnant women and children. However, traditional screening, relying on routine blood tests and requiring large automated devices, has drawbacks such as high equipment costs, complex operation, and lengthy testing cycles, complicating the need for rapid diagnosis in primary healthcare.
The Konsung Hemoglobin Analyzer (H7 series) has gradually gained popularity in anemia screening in primary healthcare facilities due to its portability and rapid detection function (detection time ≤ 3 seconds). The device employs advanced spectrophotometry to overcome the technical limitations of traditional detection. It can achieve accurate detection with a small amount of blood collected from a fingertip, significantly improving screening efficiency and convenience for patients. This article systematically evaluates the detection effectiveness of the device and its clinical value to provide a scientific basis for optimizing anemia screening programs and facilitating hierarchical medical treatment, as well as its suitability in addressing the issue of medical resource shortages at the primary level.
2. Technical Specifications of the Konsung Hemoglobin Analyzer
2.1. Detection Principle and Key Parameters
The device is based on the principle of spectrophotometry, measuring the concentration of hemoglobin in whole blood samples using the SLS-Hb method with a detection range of 0–250 g/L and a resolution of 1 g/L. Its main components include a microfluidic chip, a light source with a wavelength of 532 nm, and photoelectric sensors that calculate hemoglobin content by measuring the light absorption values of the solution after hemolysis. Clinical validation showed a correlation of 0.98 (P < 0.001) with the results of the fully automated blood analyzer Sysmex XT-1800i.
2.2. Operational Advantages and Limitations
2.2.1. Advantages
(1) Fast and Convenient: There is no need for complex sample preprocessing; only 7 µL of fingertip blood is required for testing, saving 90% of sample collection time compared to traditional routine blood tests. The device features a simple and intuitive interface, and after standardized training, non-professional medical personnel can analyze a sample in one minute, significantly increasing screening efficiency. For example, during medical examinations of the elderly, the daily testing volume can triple compared to using traditional equipment.
(2) Cost-Effectiveness: The cost of consumables for one test is 30% lower than that of a conventional blood test, and the equipment is easy to maintain and does not require frequent calibration.
(3) Use Cases: The device is compact and portable, making it particularly suitable for resource-limited situations, such as medical examination centers, blood banks, mobile blood collection points, and district hospitals. During free medical consultations in remote areas or health screenings for enterprise workers, its feature of not requiring an external power source (with a built-in battery lasting over 8 hours) effectively addresses the dependency of traditional equipment on laboratory environments and promotes the expansion of anemia screening services to local and mobile terminals.
2.2.2. Data Transmission
Equipped with data transmission capabilities via Bluetooth, the device connects to regional medical databases for real-time data exchange. Primary healthcare providers can quickly upload results to higher-level hospitals or public health platforms, simplifying the creation of patient medical records and dynamic monitoring. Analysis of significant data further assists health authorities in identifying regional anemia patterns for developing targeted prevention strategies.
2.2.3. Limitations
(1) Lack of Morphological Information: It cannot provide key parameters such as mean corpuscular volume (MCV) and red cell distribution width (RDW), which affect the identification of types of anemia;
(2) Factors Affecting Results: Hyperbilirubinemia (> 20 mg/dL) or lipemic blood samples may lead to inaccurate results.
3. New Breakthrough in Portable Hemoglobin Monitoring
3.1. Innovative Technology for Accurate Detection
The portable hemoglobin analyzer of the Konsung H7 series utilizes microfluidic and spectrophotometric technology, as well as scattering compensation technology, to ensure clinical standard accuracy (CV ≤ 1.5%). Only 7 µL of fingertip blood needs to be collected, and test results appear on a color TFT screen within 3 seconds. Storing 2000 test results provides great convenience for monitoring hemoglobin levels in daily life.
By using reliable hemoglobin determination methods and more convenient sampling techniques, Hb and HCT can be quickly and accurately detected for the diagnosis and monitoring of conditions such as anemia, polycythemia, sickle cell anemia, etc. They are widely used in blood transfusion stations and can be utilized in clinical practice, bedside examinations, medical laboratories, hospitals, etc.
3.2. Analysis of Clinical Application Cases
(1) Large-Scale Screening: Among 5000 physical examinations conducted in primary healthcare facilities, the device detected a positive result for anemia in 12.3% (616 cases), which corresponded with 91.8% of subsequent repeat blood test results;
(2) Dynamic Monitoring: Monitoring iron therapy in patients with iron deficiency anemia showed that the trend of hemoglobin level changes correlated with the improvement of clinical symptoms (r = 0.79, P < 0.01);
(3) Suitability for Specific Population Groups: In children (3–12 years), no age-related testing error was observed (P = 0.45), but attention should be paid to the cooperation of children during blood collection.
3.3. Sensitivity and Specificity
A total of 800 clinical blood samples were collected (including 220 samples from men, 300 samples from women, and 280 samples from children). Testing was performed on the automatic erythrocyte analyzer BC-5140, followed by the Konsung H7-3 hemoglobin analyzer. The sensitivity and specificity of the Konsung H7-3 hemoglobin analyzer on the overall sample were 97.32% and 90.63%, respectively.
- Male Samples (n=220): Sensitivity = 96.70%, Specificity = 94.74%
- Female Samples (n=300): Sensitivity = 96.80%, Specificity = 92.00%
- Child Samples (n=280): Sensitivity = 98.33%, Specificity = 85.00%
3.4. Quality Control
Konsung offers a comprehensive quality control program designed to monitor and verify the accuracy of test results obtained from the H7 hemoglobin analyzer. This program includes: hemoglobin quality control solution HBC-3A (levels L, M, H) and quality control chip HBQC-3C for the hemoglobin analyzer.
4. Comparison with Other Determination Methods
4.1. Microscopic method: allows for the identification of abnormal erythrocyte morphology; however, it is time-consuming (over 15 minutes per sample), and its accuracy largely depends on the knowledge and experience of the operator.
4.2. Fully automatic analyzer: offers comprehensive analysis of erythrocyte parameters with high accuracy. However, the high cost (20–50 times higher than Konsung devices) is a limiting factor.
4.3. Portable photoelectric colorimetric device: demonstrates performance comparable to the Konsung H7 hemoglobin analyzer. However, they often lack NMPA certification, which limits clinical implementation.
5. Optimization proposals and future prospects
5.1. Technology modernization: An integrated image recognition module based on artificial intelligence for semi-quantitative analysis of erythrocyte morphology by connecting to an external microscope. AI shows great potential in analyzing abnormal sizes and shapes of erythrocytes.
5.2. Multi-index tests: determining serum ferritin levels and transferrin saturation provides valuable information about iron storage and transport status, allowing for more accurate differentiation of various types of anemia.
6. Conclusion
The Konsung hemoglobin analyzer demonstrates high efficiency and cost-effectiveness in the primary screening of anemia and is an optimal tool for primary healthcare facilities where there is a general shortage of diagnostic equipment and qualified laboratory technicians.
Conflict of interest statement: The author declares no conflict of interest.